Clinical Trials · NCT01175473
Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 148
- Start date
- Aug 2010
- Locations
- 7 sites, Germany
- Primary endpoint
- Change From Baseline in Area Under the Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h) at Day 28